GIL HOFTMAN: Open Payments
NPI 1760877237 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$87,649 in 94 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $112,238 · 2025 $87,649
Speaker / faculty: $54,959Consulting: $19,870Travel & lodging: $10,520Food & beverage: $2,299
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 87 | $87,237 |
| Neuronetics, Inc. | 5 | $334 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $77 |
Products named: COBENFY, NEUROSTAR TMS THERAPY SYSTEM, CAPLYTA.
Industry payments across CA — which companies pay providers there.
